Engineering ketoreductases for the enantioselective synthesis of chiral alcohols

Journal Article (2023)
Author(s)

Li Qiao (Hangzhou Normal University)

Zhiyuan Luo (Hangzhou Normal University)

Haomin Chen (Hangzhou Normal University)

Pengfei Zhang (Hangzhou Normal University)

Anming Wang (Hangzhou Normal University)

R.A. Sheldon (TU Delft - BT/Biocatalysis, University of Witwatersrand)

Research Group
BT/Biocatalysis
Copyright
© 2023 Li Qiao, Zhiyuan Luo, Haomin Chen, Pengfei Zhang, Anming Wang, R.A. Sheldon
DOI related publication
https://doi.org/10.1039/d3cc01474f
More Info
expand_more
Publication Year
2023
Language
English
Copyright
© 2023 Li Qiao, Zhiyuan Luo, Haomin Chen, Pengfei Zhang, Anming Wang, R.A. Sheldon
Research Group
BT/Biocatalysis
Issue number
49
Volume number
59
Pages (from-to)
7518-7533
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

The use of engineered ketoreductases (KREDS), both as whole microbial cells and isolated enzymes, in the highly enantiospecific reduction of prochiral ketones is reviewed. The homochiral alcohol products are key intermediates in, for example, pharmaceuticals synthesis. The application of sophisticated protein engineering and enzyme immobilisation techniques to increase industrial viability are discussed.